Israel - Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung
Since 2014, Israel Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung fell by 0.9% year on year. With 8.5 Days in 2019, the country was number 20 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung. Costa Rica topped the ranking with 14.1 Days in 2019, an increase of 6.8% versus 2018. South Korea, Portugal and Ireland respectively ranked number 2, 3 and 4 in this ranking. Costa Rica recorded the best 5 years average growth at +2.8% per year, while Mexico recorded the worst performance at -6.2% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 8.50 |
| 2018 | 8.50 |
| 2017 | 8.80 |
| 2016 | 8.00 |
| 2015 | 9.30 |
Download all data from 2000 to 2019
How does Israel rank in Hospital Average Length of Stay for Malignant Neoplasm of Trachea, Bronchus and Lung?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Costa Rica
|
14.10 | 2019 | +6.8 % | +2.8 % | View data | |
| 2 |
#2
South Korea
|
13.70 | 2019 | -0.7 % | -0.1 % | View data | |
| 20 |
#20
Australia
|
8.50 | 2019 | +0.0 % | -0.9 % | View data | |
| 20 |
#20
Israel
|
8.50 | 2019 | +0.0 % | -0.9 % | View data | |
| 22 |
#22
Germany
|
8.10 | 2019 | -1.2 % | -0.7 % | View data | |